Tuesday 31 March, 2020 starting at 07:30-16:30
ISPOR and FDA are organising a joint summit on Using Patient-Preference Information in Medical Device Regulatory Decisions: Benefit-Risk and Beyond.
The organisers say:
“Patient-preference information (PPI) is increasingly being used in regulatory decision making for medical devices. This Summit will provide a forum to engage all stakeholders including patient representatives, medical device industry, researchers, payers and policymakers, healthcare providers, assessors, and regulators to discuss and explore the role, challenges, and opportunities of using patient-preference information across the healthcare ecosystem.
“Jointly sponsored by ISPOR—the professional society for health economics and outcomes research—and the US Food and Drug Administration (FDA) Center for Devices and Radiological Health (CDRH), this Summit offers several avenues for engagement and learning…”
Those interested can either attend in-person or via livestream. A webinar version will also be available.